Pazopanib Hydrochloride

Records for this ingredient, by country (identity only).

ATC L01XE11 · 4 markets · 27 records

Pazopanib Hydrochloride 4 markets · 27 records Forms
Filters

FR 14 records · 4 shown of 4 Source Base de données publique des médic · Data as of 2026-11-03

AU 8 records · 4 shown of 4 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 433.4 mgtabletPAZOPANIB DR. REDDY'S pazopanib (as hydrochloride) 200 mg film coated tablet bottlePAZOPANIB-RZ pazopanib (as hydrochloride) 200 mg film coated tablet bottle、VOTRIENT pazopanib 400 mg tablet bottle also in FR unknown
  • 216.7 mgtabletPAZOPANIB DR. REDDY'S pazopanib (as hydrochloride) 200 mg film coated tablet bottlePAZOPANIB-RZ pazopanib (as hydrochloride) 200 mg film coated tablet bottle、VOTRIENT pazopanib 400 mg tablet bottle also in FR unknown
  • 433 mgtabletPAZOPANIB ADVZ pazopanib (as hydrochloride) 200 mg tablet bottle unknown
  • 216.5 mgtabletPAZOPANIB ADVZ pazopanib (as hydrochloride) 200 mg tablet bottle unknown

SG 4 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 200 mgtabletPAZOPANIB-TEVA FC TABLETS 200 MGTYROKA FILM-COATED TABLETS 200 MG、VOTRIENT also in FR
  • 400 mgtabletVOTRIENT also in FR

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.